Thus, integrating the history of HIV-1 diagnosis, CD4+ T-cell count and HIV-1 RNA level and HIV-1 recency testing results into RITAs for accurate classification of HIV-1 infection status is feasible in China and provides us an opportunity to assess the role of RITAs in managing cART-treated patients. This evidence concerns the gene CD4 and HIV-1 infection.